Stock Information | The Gentian Share | Corporate Reporting | Gentian
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
15618
page-template,page-template-full_width,page-template-full_width-php,page,page-id-15618,page-child,parent-pageid-15340,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-14.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.7,vc_responsive
 

The Gentian Share

The Gentian Share: Information and news

Find stock information and news about Gentian Diagnostics AS and the Gentian share at Oslo Børs. You also find us under the ticker GENT-ME.

Shareholder structure

20 largest shareholders in Gentian Diagnostics AS as of 28.02.2019 according to VPS

ShareholderNo of Shares%
Holta Life Sciences AS2 014 70213,09 %
Vatne Equity AS1 735 34011,27 %
Safrino AS1 300 0008,44 %
Salix AS1 218 6307,92 %
Norron Sicav - Target812 3665,28 %
Silvercoin Industries AS564 1813,66 %
Vingulmork Predictor AS535 7103,48 %
Storebrand Vekst533 6523,47 %
Portia AS425 0002,76 %
Statoil Pensjon391 6312,54 %
Verdipapirfondet DNB SMB384 2492,50 %
Bård Sundrehagen307 0101,99 %
Cressida AS235 0001,53 %
Norda ASA225 4471,46 %
OM Holding AS209 0001,36 %
Marstal AS202 0001,31 %
Strawberry Capital AS200 3001,30 %
Spar Kapital Investor AS192 2911,25 %
Mutus AS187 2101,22 %
Viola AS174 9901,14 %
Other Shareholders3 547 21223,04 %
Total Shares15 395 921100 %